A real catalogue, with the limits attached.

High intent, high repeat, and a customer who actively prefers not to have the conversation in person. Compounded dose forms give you something the pharmacy down the road cannot dispense, which is what keeps it from becoming a price fight over generic tablets.

• Tadalafil orally disintegrating tablet503A compounded
  ODT, 10 mg

  No commercially available ODT form, so the dose form itself is the clinical difference rather than a copy of the tablet.

• Sildenafil and tadalafil combination troche503A compounded
  Troche

  A combination with no commercial equivalent. Onset and duration profile is the reason a clinician would choose it.

• Sildenafil, tadalafilCommercially available
  Oral tablet

  Standard generics, dispensed normally. Low margin, but it anchors price and catches customers the compounded forms are wrong for.

Treatment is indefinite by nature, so retention is structurally good. The topical combination is the product: it is the reason a customer stays with your brand instead of buying generic finasteride anywhere.

• Topical finasteride and minoxidil solution503A compounded
  Topical solution

  There is no FDA-approved topical finasteride in the US and no commercial combination product, so this is a true compound rather than a copy.

• Low-dose oral minoxidil503A compounded
  Oral, 2.5 mg

  Commercial minoxidil tablets are made for hypertension at much higher strengths; the low-dose form is a genuine compounding need.

• FinasterideCommercially available
  Oral tablet, 1 mg

  The standard of care generic. Cheap, and the entry point for most customers.

Custom-strength actives are what compounding pharmacies have always done, so the regulatory ground is solid. It is also the category where your aesthetic and your audience's trust do the most commercial work.

• Tretinoin with niacinamide503A compounded
  Cream, custom strength

  Strength and vehicle are tailored to the individual's tolerance, which is the classic patient-specific compounding case.

• Brightening combination cream503A compounded
  Cream

  Hydroquinone with tretinoin and a corticosteroid in one base. No commercial equivalent at custom strengths.

• Azelaic acid, clindamycinCommercially available
  Topical

  Standard prescription topicals for rosacea and acne.

Menopause care in particular is under-treated, and the customers are motivated, articulate and loyal. Dose individualization is real clinical practice, not a marketing story.

• Estradiol and progesterone503A compounded
  Topical cream, individualized

  Individualized strengths and combinations for patients who cannot use a commercial fixed-dose product.

• Testosterone503A compounded
  Topical cream

  Compounded strengths where the commercial gel is unsuitable. Schedule III, so handling is tighter.

• Estradiol, progesteroneCommercially available
  Oral and transdermal

  FDA-approved products, which should be the default where they fit the patient.

Lets you serve the metabolic-health audience with formulations whose legal footing does not move under you. Lower headline prices than GLP-1s, but the customer stays.

• Low-dose naltrexone503A compounded
  Oral capsule, 4.5 mg

  Commercial naltrexone is 50 mg. There is no low-dose commercial product, so this is a textbook compounding case.

• Methylcobalamin, lipotropic injection503A compounded
  Injection kit

  Combination injectables with no commercial equivalent.

• Metformin, bupropion, naltrexoneCommercially available
  Oral

  Approved products prescribed normally, where a clinician judges them appropriate.